ஆர்கிட் மருத்துவ News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆர்கிட் மருத்துவ. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆர்கிட் மருத்துவ Today - Breaking & Trending Today

NEA-backed Allay exits stealth with clinical pain data, plans to reduce need for opioids


Allay plans to start a phase 2b study this year. (Getty/JodiJacobson)
Allay Therapeutics has exited stealth armed with clinical pain data, cash from backers including NEA and plans to move its lead candidate into phase 2b this year.
The lead candidate, ATX-101, consists of the well-established intracellular sodium ion channel blocker bupivacaine and a bioresorbable polymer. When implanted during total knee replacement surgery, the candidate is designed to release half of the suspended bupivacaine over the first few days to allay breakthrough pain and then issue less and less of the painkiller as the patient recovers.
Allay now has clinical data from a 22-patient phase 1b/2a trial to back up its belief in the approach. In describing the data, Allay focused on the patients who received 1,500 mg of ATX-101, the highest dose used in the trial. ....

Allay Therapeutics , Lightstone Venture Singapore , Orchid Medical , Pain Therapy , ஆர்கிட் மருத்துவ , வலி சிகிச்சை ,